These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 12047143

  • 1. HER2/neu amplification in breast cancer: stratification by tumor type and grade.
    Hoff ER, Tubbs RR, Myles JL, Procop GW.
    Am J Clin Pathol; 2002 Jun; 117(6):916-21. PubMed ID: 12047143
    [Abstract] [Full Text] [Related]

  • 2. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
    Latta EK, Tjan S, Parkes RK, O'Malley FP.
    Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
    [Abstract] [Full Text] [Related]

  • 3. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
    Ariga R, Zarif A, Korasick J, Reddy V, Siziopikou K, Gattuso P.
    Breast J; 2005 Dec; 11(4):278-80. PubMed ID: 15982396
    [Abstract] [Full Text] [Related]

  • 4. Her-2/neu gene amplification in ductal carcinoma in situ of the breast.
    Hoque A, Sneige N, Sahin AA, Menter DG, Bacus JW, Hortobagyi GN, Lippman SM.
    Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):587-90. PubMed ID: 12050101
    [Abstract] [Full Text] [Related]

  • 5. Amplification and overexpression of HER2/neu gene and HER2/neu protein in salivary duct carcinoma of the parotid gland.
    Cornolti G, Ungari M, Morassi ML, Facchetti F, Rossi E, Lombardi D, Nicolai P.
    Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1031-6. PubMed ID: 17938328
    [Abstract] [Full Text] [Related]

  • 6. Genotypic intratumoral heterogeneity in breast carcinoma with HER2/neu amplification: evaluation according to ASCO/CAP criteria.
    Brunelli M, Manfrin E, Martignoni G, Miller K, Remo A, Reghellin D, Bersani S, Gobbo S, Eccher A, Chilosi M, Bonetti F.
    Am J Clin Pathol; 2009 May; 131(5):678-82. PubMed ID: 19369627
    [Abstract] [Full Text] [Related]

  • 7. Analysis of the cellular centrosome in fine-needle aspirations of the breast.
    Guo HQ, Gao M, Ma J, Xiao T, Zhao LL, Gao Y, Pan QJ.
    Breast Cancer Res; 2007 May; 9(4):R48. PubMed ID: 17662154
    [Abstract] [Full Text] [Related]

  • 8. HER2 genetic heterogeneity in breast carcinoma.
    Ohlschlegel C, Zahel K, Kradolfer D, Hell M, Jochum W.
    J Clin Pathol; 2011 Dec; 64(12):1112-6. PubMed ID: 22011446
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intratumoral heterogeneity of HER2/neu in breast cancer--a rare event.
    Hanna W, Nofech-Mozes S, Kahn HJ.
    Breast J; 2007 Dec; 13(2):122-9. PubMed ID: 17319852
    [Abstract] [Full Text] [Related]

  • 11. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
    Sullivan PS, Apple SK.
    Breast J; 2009 Dec; 15(2):146-54. PubMed ID: 19292800
    [Abstract] [Full Text] [Related]

  • 12. A data model to predict HER2 status in breast cancer based on the clinical and pathologic profiles of a large patient population at a single institution.
    Crowe JP, Patrick RJ, Rybicki LA, Escobar PF, Weng D, Thomas Budd G, Tubbs RR, Procop GW, Hicks DG.
    Breast; 2006 Dec; 15(6):728-35. PubMed ID: 16716590
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Her-2 amplification and p185 expression in invasive breast cancer cells in women].
    Titi S.
    Ann Acad Med Stetin; 2006 Dec; 52(2):5-12. PubMed ID: 17633393
    [Abstract] [Full Text] [Related]

  • 15. Analysis of the HER2/neu gene amplification in microdissected breast cancer tumour samples.
    Seth RM, Burger AM, Kahn HJ.
    Anticancer Res; 2006 Dec; 26(2A):927-31. PubMed ID: 16619488
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S, Russo R, Ciancia G, Altieri V, De Rosa G, Insabato L.
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.